Blackrock Health Sciences Stock Net Income
| BMEZ Stock | USD 15.25 0.19 1.23% |
As of the 28th of January, BlackRock Health shows the risk adjusted performance of 0.0485, and Mean Deviation of 0.7711. BlackRock Health Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BlackRock Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BlackRock Health's valuation are provided below:BlackRock Health Sciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. BlackRock | Build AI portfolio with BlackRock Stock |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BlackRock Health. Projected growth potential of BlackRock fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BlackRock Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate BlackRock Health Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BlackRock Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause BlackRock Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between BlackRock Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BlackRock Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BlackRock Health's market price signifies the transaction level at which participants voluntarily complete trades.
BlackRock Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BlackRock Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BlackRock Health.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in BlackRock Health on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding BlackRock Health Sciences or generate 0.0% return on investment in BlackRock Health over 90 days. BlackRock Health is related to or competes with BlackRock Capital, BlackRock ESG, BlackRock Science, Blackrock Municipal, World Growth, Blackrock Enhanced, and Schwab Target. More
BlackRock Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BlackRock Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BlackRock Health Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.794 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 4.64 | |||
| Value At Risk | (1.27) | |||
| Potential Upside | 2.1 |
BlackRock Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BlackRock Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BlackRock Health's standard deviation. In reality, there are many statistical measures that can use BlackRock Health historical prices to predict the future BlackRock Health's volatility.| Risk Adjusted Performance | 0.0485 | |||
| Jensen Alpha | 0.0202 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1049 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BlackRock Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BlackRock Health January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0485 | |||
| Market Risk Adjusted Performance | 0.1149 | |||
| Mean Deviation | 0.7711 | |||
| Semi Deviation | 0.7153 | |||
| Downside Deviation | 0.794 | |||
| Coefficient Of Variation | 1607.24 | |||
| Standard Deviation | 1.01 | |||
| Variance | 1.03 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.0202 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.1049 | |||
| Maximum Drawdown | 4.64 | |||
| Value At Risk | (1.27) | |||
| Potential Upside | 2.1 | |||
| Downside Variance | 0.6304 | |||
| Semi Variance | 0.5116 | |||
| Expected Short fall | (1.00) | |||
| Skewness | 0.8977 | |||
| Kurtosis | 0.7729 |
BlackRock Health Sciences Backtested Returns
At this stage we consider BlackRock Stock to be very steady. BlackRock Health Sciences secures Sharpe Ratio (or Efficiency) of 0.0622, which signifies that the company had a 0.0622 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for BlackRock Health Sciences, which you can use to evaluate the volatility of the firm. Please confirm BlackRock Health's risk adjusted performance of 0.0485, and Mean Deviation of 0.7711 to double-check if the risk estimate we provide is consistent with the expected return of 0.063%. BlackRock Health has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BlackRock Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding BlackRock Health is expected to be smaller as well. BlackRock Health Sciences right now shows a risk of 1.01%. Please confirm BlackRock Health Sciences value at risk, and the relationship between the standard deviation and kurtosis , to decide if BlackRock Health Sciences will be following its price patterns.
Auto-correlation | 0.66 |
Good predictability
BlackRock Health Sciences has good predictability. Overlapping area represents the amount of predictability between BlackRock Health time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BlackRock Health Sciences price movement. The serial correlation of 0.66 indicates that around 66.0% of current BlackRock Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, BlackRock Health Sciences reported net income of 23.45 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is notably lower than that of the firm.
BlackRock Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BlackRock Health could also be used in its relative valuation, which is a method of valuing BlackRock Health by comparing valuation metrics of similar companies.BlackRock Health is currently under evaluation in net income category among its peers.
BlackRock Fundamentals
| Shares Outstanding | 62.5 M | |||
| Shares Owned By Institutions | 17.51 % | |||
| Number Of Shares Shorted | 15.91 K | |||
| Price To Book | 1.01 X | |||
| Price To Sales | 23.37 X | |||
| Revenue | 24.07 M | |||
| EBITDA | 23.5 M | |||
| Net Income | 23.45 M | |||
| Total Debt | 278.06 K | |||
| Cash Flow From Operations | 65.52 M | |||
| Short Ratio | 0.06 X | |||
| Earnings Per Share | (0.12) X | |||
| Market Capitalization | 1.56 B | |||
| Total Asset | 774.59 M | |||
| Retained Earnings | (173.53 M) | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 774.59 M |
About BlackRock Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BlackRock Stock Analysis
When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.